Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation

被引：0
|
作者：
Dhanashree Ratra
Krishnakanta Roy
Sneha Giridhar
Sushant Madaan
机构：
[1] Medical Research Foundation,Department of Vitreoretinal Diseases
[2] Sankara Nethralaya,undefined
来源：
Ophthalmology and Therapy | 2022年 / 11卷
关键词：
Anti VEGF; Biosimilar; Comparison with bevacizumab; DME; nAMD; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：135 / 149
页数：14
相关论文
共 50 条
  • [41] Real-world outcomes of ranibizumab treatment in patients with retinal vein occlusion: the LUMINOUS™ study
    Pearce, Ian A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [42] Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
    Chang, Yi-Sheng
    Lee, Wan-Ju
    Lim, Chen-Chee
    Wang, Shih-Hao
    Hsu, Sheng-Min
    Chen, Yi-Chian
    Cheng, Chia-Yi
    Teng, Yu-Ti
    Huang, Yi-Hsun
    Lai, Chun-Chieh
    Tseng, Sung-Huei
    SCIENTIFIC REPORTS, 2018, 8
  • [43] AGE RELATED MACULAR DEGENERATION Cost comparison of ranibizumab and bevacizumab
    Jackson, Timothy L.
    Kirkpatrick, Lucy
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [44] Safety Profile Comparison Between Topical Pegaptanib (Macugen®), Bevacizumab (Avastin®) and Ranibizumab (Lucentis®)
    Bucher, F.
    Bock, F.
    Hos, D.
    Cursiefen, C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [45] Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
    Yi-Sheng Chang
    Wan-Ju Lee
    Chen-Chee Lim
    Shih-Hao Wang
    Sheng-Min Hsu
    Yi-Chian Chen
    Chia-Yi Cheng
    Yu-Ti Teng
    Yi-Hsun Huang
    Chun-Chieh Lai
    Sung-Huei Tseng
    Scientific Reports, 8
  • [46] Real-world outcomes of ranibizumab in patients with retinal vein occlusion from the LUMINOUS™ study
    Pearce, Ian
    Parikh, Soumil
    Macfadden, Wayne
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [47] Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice
    Yang, Jingyan
    Kelton, John Mark
    Thompson, Jeffrey
    Alvir, Jose Maria Jimenez
    Maculaitis, Martine C.
    Shelbaya, Ahmed
    AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (04): : 160 - 166
  • [48] Comparison of Intravitreal Bevacizumab and Ranibizumab Treatment for Diabetic Macular Edema
    Ozturk, Banu Turgut
    Kerimoglu, Hurkan
    Bozkurt, Banu
    Okudan, Suleyman
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (04) : 373 - 377
  • [49] Real-world treatment of diabetic macular oedema: a comparison of combined ranibizumab plus macular LASER with macular LASER monotherapy
    Zygoura, Vasiliki
    Papavasileiou, Evangelia
    Vavvas, Demetrios G.
    Cortis, Dominic
    Eleftheriadis, Haralabos
    Jackson, Timothy L.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2015, 18 (03): : 33 - 41
  • [50] Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer
    Rhodes, Whitney
    DeClue, Richard W.
    Accortt, Neil A.
    Jin, Ran
    Sandschafer, Darcie
    Wertz, Debra
    Patel, Kashyap
    FUTURE ONCOLOGY, 2021, 17 (36) : 5119 - 5127
12345